Dyne Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
DYN on Nasdaq
Industry
Pharmaceutical Preparations
Location
1560 Trapelo Road, Waltham, MA

Insiders trading volume in the past year

Dyne Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Atlas Venture Fund XI, L.P. 10%+ Owner $166M -$42.8M -20.5% Feb 26, 2024
Atlas Venture Opportunity Fund I, L.P. 10%+ Owner $69.3M -$1.4M -1.98% Mar 1, 2024
Atlas Venture Opportunity Fund II, L.P. 10%+ Owner $44.5M Dec 12, 2022
Jason P. Rhodes Director $25.5M -$44.2M -63.5% May 22, 2024
Dirk Kersten Director $14M -$51.9M -78.8% Sep 5, 2024
Joshua T. Brumm CEO & President, Director $14M -$19.5M -58.3% Mar 8, 2024
Wildon Farwell Chief Medical Officer $6.59M -$757K -10.3% Aug 19, 2024
Jonathan McNeill Chief Business Officer $6.08M -$5.04M -45.3% Aug 19, 2024
Oxana Beskrovnaya Chief Scientific Officer $4.55M -$3.11M -40.6% Sep 11, 2024
Susanna Gatti High Chief Operating Officer $4.48M -$8.04M -64.2% Sep 11, 2024
Richard Scalzo SVP, Head of Finance & Admin. $3.19M -$7.78M -70.9% Sep 11, 2024
Johanna Friedl-Naderer Chief Commercial Officer $2.68M Sep 3, 2024
Douglas Kerr Chief Medical Officer $2.18M Sep 3, 2024
John Cox CEO & President, Director $1.22M +$1.06M +633% Sep 4, 2024
David Lubner Director May 22, 2024
Lawrence Klein Director Jul 5, 2022
Carlo Incerti Director May 22, 2024
Edward Hurwitz Director May 22, 2024
Catherine Stehman-Breen Director May 22, 2024

Recent Insider Transactions by Companies or Individuals for Dyne Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.